1. AHRO : Austin Health Research Online
  2. Austin Health research
  3. Journal articles
Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/26352
Full metadata record
DC FieldValueLanguage
dc.contributor.authorLiew, David F L-
dc.contributor.authorDau, Jonathan-
dc.contributor.authorRobinson, Philip C-
dc.date2021-04-28-
dc.date.accessioned2021-05-03T05:19:40Z-
dc.date.available2021-05-03T05:19:40Z-
dc.date.issued2021-04-28-
dc.identifier.citationCurrent Rheumatology Reports 2021; 23(6): 36en
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/26352-
dc.description.abstractThis review examines axial spondyloarthritis (axSpA) and the wider field of rheumatology through a value-based healthcare (VBHC) lens. VBHC is focused on ensuring patients receive high quality care to improve outcomes and reduce unnecessary costs. There are many opportunities to apply the principles of VBHC in axSpA. These include the appropriate utilization of diagnostic investigations, such as HLA-B27 and magnetic resonance imaging, assessing outcomes meaningful to patients, and optimizing care pathways. Multidisciplinary care may improve value, and reduced specialist review and medication tapering may be appropriate. Increasing the value of the care we provide to patients can occur across domains and directly and indirectly improves patient outcomes. Taking the time to integrate principles of VBHC into our practice will allow us to justifiably gain and maintain access to diagnostic and therapeutic advances for the benefit of all our patients.en
dc.language.isoeng-
dc.subjectAnkylosing spondylitisen
dc.subjectAxial spondyloarthritisen
dc.subjectDiagnosisen
dc.subjectHealth economicsen
dc.subjectLow benefit careen
dc.subjectPharmacoeconomicsen
dc.subjectRheumatologyen
dc.subjectTreatment strategyen
dc.subjectValue-based healthcareen
dc.titleValue-Based Healthcare in Rheumatology: Axial Spondyloarthritis and Beyond.en
dc.typeJournal Articleen
dc.identifier.journaltitleCurrent Rheumatology Reportsen
dc.identifier.affiliationDepartment of Medicine, University of Melbourne, Parkville, Victoria, Australiaen
dc.identifier.affiliationDivision of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Boston, MA, USAen
dc.identifier.affiliationDepartment of Rheumatology, Royal Brisbane & Women's Hospital, Metro North Hospital & Health Service, Bowen Bridge Road, Herston, Queensland, 4006, Australiaen
dc.identifier.affiliationFaculty of Medicine, University of Queensland School of Clinical Medicine, Herston, Queensland, 4006, Australiaen
dc.identifier.affiliationDepartment of Clinical Pharmacology and Therapeutics, Austin Health, Heidelberg, Victoria, Australiaen
dc.identifier.affiliationRheumatologyen
dc.identifier.doi10.1007/s11926-021-01003-zen
dc.type.contentTexten
dc.identifier.orcid0000-0001-8451-8883en
dc.identifier.orcid0000-0002-3156-3418en
dc.identifier.pubmedid33909169-
local.name.researcherLiew, David F L
item.openairetypeJournal Article-
item.cerifentitytypePublications-
item.grantfulltextnone-
item.fulltextNo Fulltext-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.languageiso639-1en-
crisitem.author.deptRheumatology-
crisitem.author.deptClinical Pharmacology and Therapeutics-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

28
checked on Nov 25, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.